Hinxton, United Kingdom
The Wellcome Trust Sanger Institute will open a $42 million genome sequencing facility in August of 2015 in Hinxton in the United Kingdom. The three-story, 51,667-sf project is located near Cambridge on the Institute's biomedical research campus. The sequencing facility is an integral part of the master plan for the site, which will include a 38,750-sf bio-data innovation center. The Sanger Institute is operated by Genome Research Limited, a wholly owned subsidiary of the Wellcome Trust.
